![]() |
Volumn 94, Issue 4, 2000, Pages 429-431
|
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
|
Author keywords
Adverse events; Chemotherapy; Clinical trial; Drug combinations; Efficacy; India; Paromomycin; Sodium stibogluconate; Visceral leishmaniasis
|
Indexed keywords
AMINOGLYCOSIDE;
PAROMOMYCIN;
STIBOGLUCONATE SODIUM;
ADOLESCENT;
ADULT;
ARTICLE;
AUDIOGRAPHY;
CARDIOTOXICITY;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROCARDIOGRAM;
FEMALE;
FOLLOW UP;
HUMAN;
INDIA;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MYOCARDITIS;
OTOTOXICITY;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
TREATMENT OUTCOME;
VISCERAL LEISHMANIASIS;
PROTOZOA;
|
EID: 0033847913
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(00)90130-5 Document Type: Article |
Times cited : (100)
|
References (14)
|